Therefore, SYMLIN should be administered to nursing women only if it is determined by the healthcare professional that the potential benefit outweighs the potential risk to the infant. 8.4 Pediatric Use Safety and effectiveness of SYMLIN in pediatric patients have not been established. 8.5 Geriatric Use SYMLIN has been studied in patients ranging in age from 15 to 84 years of age, including 769 pa